Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 18 of 29
-
World Hepatitis Day 2019: 1.4 million lives lost since last year
Today, 28 July, is World Hepatitis Day 2019. Since the day was marked in 2018, another 1.4 million people have...
-
ITPC’s IAS 2019 highlights!
The International AIDS Society (IAS) conferences are always bursting with events, announcements and debates, and the 10th International Conference on...
-
IAS 2019: Activists demand universal access to medicines
Today in Mexico City, dozens of treatment activists at the International AIDS Society (IAS) conference took over several drug company...
-
AIDS activists demand access to important cryptococcal meningitis drug
At the 10th International HIV Conference on Science (IAS 2019) taking place in Mexico City, AIDS activists protested Gilead’s inaction...
-
The right to health is compulsory: Time for action on dolutegravir – now!
Why Algeria, Azerbaijan, Belarus, Brazil, Bulgaria, China, Colombia, Kazakhstan, Mexico, Romania, Russia, and Turkey must issue compulsory licences on dolutegravir...
-
Still an avoidable tragedy: Brazil’s view on the EU-Mercosur free-trade agreement
The signing of the Free Trade Agreement (FTA) between Mercosur and the European Union on 28 June 2019, means that...
-
Old wine in new bottles: Keep TRIPS-plus provisions out of the RCEP FTA!
Intellectual property barriers, which would hinder access to affordable medicines, have supposedly been removed from the draft RCEP free-trade agreement...
-
Ukraine hosts regional congress on intellectual property and access to medicines
Over 100 people from more than 10 countries met in Kiev for the ‘Congress on Intellectual Property (IP) and Access...
-
Drug users under the microscope: Temo’s experience in Georgia
“I was in prison when I was diagnosed with Hepatitis B,” says Temo, 33. “I was just left with the...
-
Ukraine: First civil society organization to oppose Merck’s patent application ( MK-8591) on the grounds of “obviousness”
On 28 May 2019, 100 Percent Life (the Network) submitted an opposition to the Ukrainian Patent and Trademark Office against...
-
Politics of Death: The End of Brazil’s Department of AIDS
Adapted from a post published by ABIA, Global AIDS Policy Watch: A joint story from Brazilian NGOs that have denounced...
-
Pipeline patents – Brazilian Supreme Court decides on the present and the future
On Wednesday 22 May, the largest trial in the history of the Brazilian Federal Supreme Court (STF) involving the pharmaceutical...